SynthesisJournal of managed care & specialty pharmacy2023
Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review.
Synthesis in Journal of managed care & specialty pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Expanding the Catalog of Patient and Caregiver Out-of-Pocket Costs: A Systematic Literature Review.Population health management · 2024Pooled it
- Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital.Journal of comparative effectiveness research · 2026Review
- Incidence and etiology of impediments to spinal cord stimulator trial progression.Interventional pain medicine · 2026Article
- Primary Care Cost Sharing in Medicare Advantage.JAMA health forum · 2026Article
- Definition of treatment-resistant late-life depression: Conclusions from a European Task Force Delphi process.European psychiatry : the journal of the Association of European Psychiatrists · 2026Article
- The 6-item InCharge financial distress/financial wellbeing (IFDFW-6) scale: Development and validation in pharmacy and epidemiology research.Exploratory research in clinical and social pharmacy · 2026Article
- Socioeconomic Determinants of Access to Medicines Among Romanian Patients with Chronic Diseases: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Patient out-of-pocket costs and rheumatology biosimilar competition.Journal of managed care & specialty pharmacy · 2026Article
- Association Between Copayments and Attendance in Cardiac Rehabilitation: A Nationwide Analysis From the AACVPR Registry.Journal of the American Heart Association · 2026Article
- Medicare Advantage Benefits Design and Access to Cardiovascular Care.JAMA network open · 2026Article
- Predictive factors for care intensification in a no co-pay physical therapy model for musculoskeletal pain.BMC health services research · 2026Article
- Potential Impact of the Medicare Prescription Payment Plan for Medicare Part D Beneficiaries With a Cancer Diagnosis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026Article
- Trends in prescription drug coverage restrictions in Medicare, Medicaid, and commercial insurance plans, 2011-2019.Health affairs scholar · 2026Article
- A primer on clinical programs in managed care pharmacy.Journal of managed care & specialty pharmacy · 2026Review
- Socioeconomic, demographic, and medication class determinants of medication adherence: A retrospective cohort study.Journal of managed care & specialty pharmacy · 2026Article
- Tertiary Patents on Drugs Approved by the FDA.JAMA health forum · 2026Article
- Article
- The Pharmacoeconomics and its Evaluation in Enhancing the Indian Healthcare System.Current drug research reviews · 2026Review
- Health Insurance Schemes and Chronic Disease Management Behaviours in China: Evidence from Women with Non-Communicable Diseases.Risk management and healthcare policy · 2026Article
- Patient Perspectives on Health Insurance Design: A Mixed-Methods Analysis.Journal of market access & health policy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.